(Q34613889)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

Heart rate variability--a therapeutic target? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

main subject

heart rate variability

0 references

author

Jonathan N Townend

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

H C Routledge

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S Chowdhary

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Pharmacy and Therapeutics

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

85-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

21 January 2018

Baroreflex sensitivity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Power spectral analysis of cardiovascular variability in patients at risk for sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Inhibition by acetylcholine of adrenergic neurotransmission in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Role of the vagus nerves in the cardiovascular changes induced by coronary occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Basis for Recurring Ventricular Fibrillation in the Absence of Coronary Heart Disease and Its Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Beta-adrenergic blockade may prolong life in post-infarction patients in part by increasing vagal cardiac inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Angiotensin inhibits action of vagus nerve at the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Aldosterone reduces baroreceptor discharge in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2002.00404.X

10.1046/J.1365-2710.2002.00404.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11975691%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference